SCHEMBL3252170

SCHEMBL3252170

O=C(O)Cc1cnc(NS(=O)(=O)c2ccc(-c3ccccc3)cc2)s1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 3/20 0.48
MMP12 P39900 3/20 0.48
GAA P10253 2/20 0.48
EGLN1 Q9GZT9 1/20 0.45
ALOX12 P18054 2/20 0.45
CCNE2 O96020 1/20 0.44
CCNE1 P24864 1/20 0.44
CDK2 P24941 1/20 0.44
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
HTT P42858 2/20 0.44
LMNA P02545 1/20 0.44
MAPK1 P28482 2/20 0.44
MAPT P10636 1/20 0.44
RECQL P46063 1/20 0.44
UQCRB P14927 1/20 0.44
KDM1A O60341 1/20 0.44
SCN3A Q9NY46 1/20 0.42
MMP9 P14780 3/20 0.42
MMP8 P22894 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3250221 0.87 KDM4E (0.49) MMP1HTTLMNAMMP13ADAMTS4
SCHEMBL3255724 0.86 LMNA (0.49) EGLN1ALOX12MEN1KMT2AHTT
SCHEMBL3251733 0.86 ALDH1A1 (0.46) GAAMEN1KMT2AHTTLMNA
SCHEMBL3256609 0.85 MEN1 (0.43) GAAEGLN1ALOX12CCNE2CCNE1
SCHEMBL3254141 0.85 ALOX12 (0.44) MMP1GAAALOX12CCNE2CCNE1
SCHEMBL3251115 0.84 ALOX12 (0.44) MMP1GAAALOX12CCNE2CCNE1
SCHEMBL3256780 0.84 ALOX12 (0.42) MMP1MMP12GAAALOX12CCNE2
SCHEMBL3255956 0.84 ALOX12 (0.43) MMP1MMP12GAAEGLN1ALOX12
SCHEMBL3250348 0.84 HSD11B1 (0.52) GAAMEN1KMT2AHTTLMNA
SCHEMBL3253529 0.83 ALDH1A1 (0.52) EGLN1MEN1KMT2AMAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1461325-B1 INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE 1 BIOVITRUM AB (SE) 2010-05-26 EP claimed
US-7671051-B2 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 BIOVITRUM AB (SE) 2010-03-02 US claimed
US-20050250776-A1 Inhibitors of 11-beta-hydroxy steriod dehydrogenase type 1 BIOVITRUM AB 2005-11-10 US claimed
US-20030130318-A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 BIOVITRUM AB (SE) 2003-07-10 US claimed
EP-1461325-B1 INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE 1 BIOVITRUM AB (SE) 2010-05-26 EP disclosed
US-7671051-B2 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 BIOVITRUM AB (SE) 2010-03-02 US disclosed
US-7094792-B2 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 BIOVITRUM AB (SE) 2006-08-22 US disclosed
US-20050250776-A1 Inhibitors of 11-beta-hydroxy steriod dehydrogenase type 1 BIOVITRUM AB 2005-11-10 US disclosed
US-20030130318-A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 BIOVITRUM AB (SE) 2003-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050250776-A1 Inhibitors of 11-beta-hydroxy steriod dehydrogenase type 1 HSD11B1, HSD17B1, HSD17B11 MMP1 687/4885MMP12 1766/4885GAA 567/4885
US-20030130318-A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 HSD11B1, HSD17B1, HSD3B1 MMP1 481/4885MMP12 1181/4885GAA 351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.